Revolutionary Advancements in Mammography AI: Lifesaving Breakthroughs

October 02, 2023
Category: iNFORMED - Blog

Every October, we shine a spotlight on breast cancer during National Breast Cancer Awareness Month. Thanks to the remarkable innovations in AI (Artificial Intelligence), we have more reasons to raise awareness about advancements in mammography than ever before. AI-powered mammography is revolutionizing care for patients' breast health by finding cancers earlier, with greater accuracy and efficiency, standardizing assessments of breast density, and offering personalized evaluations for each patients’ risk of developing breast cancer in the next 1 – 2 years.


Improved Accuracy and Peace of Mind


Much like the significant s... Continue reading

Tags: Artificial Intelligence Breast Cancer Detection Breast Tomosynthesis Breast Density Density Assessment Software Technology
ProFound-Lifesaving-Breakthrough.jpg

Embracing Clarity: Celebrating the 2nd Annual World Dense Breast Day

September 27, 2023
Category: iNFORMED - Blog

At iCAD, we are recognizing the 2nd annual World Dense Breast Day today, a day that holds significant importance, not only for the women who may have dense breasts but for all of us dedicated to advancing breast health awareness and early cancer detection.


As we gather to mark this event, it's essential to reflect on how far we've come in the journey towards eradicating the shadows that cancer casts. At iCAD, we're committed to creating a world where cancer can't hide. And this year, we have some exciting developments to share, especially concerning one of the strongest and most prevalent breast cancer risk factors—dense brea... Continue reading

Tags: Artificial Intelligence Breast Density Density Assessment Software Technology
The_2nd_Annual_World_Breast_Density_Day.jpg

Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment

August 16, 2023
Category: Press Releases

NASHUA, N.H., August 16, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Health Canada has issued a device license for ProFound Risk version 2.0, the latest version of iCAD's personalized 1-2 year breast cancer risk assessment solution.

 

"We are delighted to receive the device license from Health Canada for the latest version of ProFound Risk, marking a major milestone in our mission to help women worldwide know where and when breast cancer may be hiding," sa... Continue reading

Tags: press releases

iCAD Reports Financial Results for Second Quarter Ended June 30, 2023

August 14, 2023
Category: Press Releases

Company to host conference call and webcast today at 4:30 PM ET


NASHUA, N.H. – August 14, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported its financial and operating results for the three and six months ended June 30, 2023.


Highlights:

iCAD signs 20-year worldwide development and commercialization agreement with Google Health to integrate Google’s AI technology with its ProFound Detection for 2D Mammography for use upon regulatory approval as an independent reader for breast cancer screening.iCAD signs strategic multi-yea... Continue reading
Tags: press releases

Joining Forces with Google to Revolutionize Breast Cancer Screening Worldwide

August 14, 2023
Category: iNFORMED - Blog

by Dana Brown, President and CEO of iCAD, Inc.

 

We’ve joined forces with Google Health once again to address two of the most pressing challenges in healthcare: the global radiologist shortage and significant disparities in healthcare.

 

Per our 20-year worldwide agreement, Google's AI technology will seamlessly integrate into our ProFound Breast Health Suite, including ProFound Detection, for use as an independent reader for breast cancer screening with 2D... Continue reading

Tags: 3D Mammography Artificial Intelligence Breast Cancer Detection Breast Tomosynthesis Software Technology
google-health.jpg

iCAD and Google Health Expand Integration of Google’s AI Technology with iCAD’s ProFound Breast Health Suite for 2D Mammography for Use as Independent Reader

August 14, 2023
Category: Press Releases

Worldwide commercialization agreement offers potential to ease radiologist workload and reduce healthcare disparities for women

 

NASHUA, N.H., August 14, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it signed an amendment to its development and commercialization agreement with Google Health, which will enable iCAD to integrate Google’s AI technology with its ProFound Breast Health Suite for 2D Mammography for use worldwide upon regulatory appr... Continue reading

Tags: press releases

iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023

July 31, 2023
Category: Press Releases

NASHUA, N.H., July 31, 2023 -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will release financial results for the second quarter of 2023 and host a conference call at 4:30 PM ET on Monday, August 14, 2023.

 

Earnings call details are as follows:

 

Domestic: 888-506-0062

International: 973-528-0011

Participant Access Code: 460678

Continue reading

Tags: press releases

iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nation’s Largest Radiology Practice

July 18, 2023
Category: Press Releases

Agreement positions iCAD as Radiology Partners’ breast AI provider, expanding potential for iCAD’s technology to reach millions of women in the U.S.


NASHUA, N.H., July 18, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it has signed a new strategic multi- year commercial agreement with Radiology Partners, the nation’s largest radiology practice through its owned and affiliated practices.


Under the agreement, which was executed on June 27, Radiology Partners selected iCAD as its provider of breast AI technologies deployed t... Continue reading

Tags: press releases

iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Cleveland Clinic

July 12, 2023
Category: Press Releases

Cleveland Clinic breast radiologist, Laura Dean, MD, to discuss how iCAD’s Breast AI Suite helps her detect the breast cancers radiologists fear most

 

NASHUA, N.H., July 12, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its “ProFound Insights, ProFound Impact” webinar series will feature Dr. Laura Dean, a renowned breast radiologist at the Cleveland Clinic. Titled “How Cleveland Clinic is Finding the Breast Cancers Radio... Continue reading

Tags: press releases

iCAD Offers ROI Analysis Based on Real-World Results from its ProFound Breast AI Suite at AHRA Annual Meeting

July 10, 2023
Category: Press Releases

Company’s ROI Tool offers preview of business value the ProFound Breast AI Suite offers to clinicians and imaging facilities

 

NASHUA, N.H., July 10, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it is showcasing its ProFound AI Suite of clinically proven solutions for breast cancer detection, density assessment, and short-term risk evaluation in booth #228 at the AHRA 2023 annual meeting, taking place July 9-12 in Ind... Continue reading

Tags: press releases

iCAD’s Breast AI Suite Wins U.S. General Services Administration’s AI Healthcare Challenge Award

May 18, 2023
Category: Press Releases

Company presented portfolio of breast cancer detection, density assessment and risk evaluation solutions at the competition, focused on improving health outcomes

 

NASHUA, N.H., May 18, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its Breast AI Suite is a winner of the U.S. General Services Administration’s (GSA) “AI Healthcare Challenge” award. iCAD presented its portfolio of breast cancer detection, density assessment and risk evaluation solutions at the competiti... Continue reading

Tags: press releases

iCAD Reports Financial Results for First Quarter Ended March 31, 2023

May 15, 2023
Category: Press Releases

Company to host conference call and webcast today at 4:30 PM ET 

 

NASHUA, N.H. – May 15, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported its financial and operating results for the three months ended March 31, 2023. 

 

Highlights:


Body of evidence supporting iCAD’s technologies grows, with compelling new research supporting Company’s Breast AI Suite and... Continue reading
Tags: press releases

New Long-Term Real-World Research Confirms Xoft Skin eBx is as Safe and Effective as Mohs Surgery

May 11, 2023
Category: Press Releases

98.9% of patients treated with Xoft remained recurrence-free at a median follow-up of 7.6 years, according to recent study published in Journal of Contemporary Brachytherapy

 

NASHUA, N.H., May 11, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced compelling new long-term real-world research confirms Xoft Skin eBx is as safe and effective as Mohs surgery for the treatment of non-melanoma skin cancer (NMSC). In the longest-term study of Xof... Continue reading

Tags: press releases

iCAD Showcases Breast AI Suite at Society of Breast Imaging Symposium, World’s Largest Breast Imaging Conference

May 03, 2023
Category: Press Releases

iCAD’s AI solution minimizes interval cancers and overcomes challenges associated with digital breast tomosynthesis

 

NASHUA, N.H., May 3, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will showcase its Breast AI Suite of cancer detection, density assessment and risk evaluation solutions at the world’s largest breast imaging conference, the Society of Breast Imaging (SBI) Symposium, taking place May 4-7 in National Harbor, MD. Attendees are i... Continue reading

Tags: press releases

iCAD to Report First Quarter 2023 Financial Results on May 15, 2023

May 01, 2023
Category: Press Releases

NASHUA, N.H., May 1, 2023 -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the first quarter ended March 31, 2023, after the market close, and host a conference call at 4:30 PM Eastern Time on Monday, May 15, 2023.

 

Earnings call details are as follows:

 

Domestic: 877-545-0523

International: 973-528-0016

Continue reading

Tags: press releases

iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Boca Raton Regional Hospital

April 25, 2023
Category: Press Releases

Kathy Schilling, MD, Boca Raton Regional Hospital, to discuss how ProFound AI helped nine dedicated breast radiologists find 23% more cancers, without increasing the rate of recalls

 

NASHUA, N.H., April 25, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its “ProFound Insights, ProFound Impact” webinar series will feature Kathy Schilling, MD, Medical Director, Christine E. Lynn Women's Health & Wellness Institute, Boca Raton Regional Hospital. The live event,... Continue reading

Tags: press releases

New and Real-World Clinical Evidence Confirms ProFound AI Increases Cancer Detection and Reveals Critical Clues to Inform Clinical Decisions

April 20, 2023
Category: Press Releases

New research presented at American Roentgen Ray Society (ARRS) meeting continues to validate unique value iCAD’s deep-learning breast AI solution offers to clinicians and patients

   

NASHUA, N.H., April 20, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new real-world research confirms ProFound AI® has been proven to increase cancer detection rates and provide vital clues for breast imagers' clinical decisions through two studies. One... Continue reading

Tags: Press Releases

iCAD Strengthens Leadership Team with Appointment of Chief Financial Officer and New Senior Executives

April 17, 2023
Category: Press Releases

Eric Lonnqvist as Chief Financial Officer, Vasu Avadhanula as Chief Product Officer, and Michelle Strong as Chief Operations Officer bolster the Company’s executive leadership team and accelerate the Company’s growth strategies

 

NASHUA, N.H., April 17, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Board of Directors has approved the appointment of Eric Lonnqvist as Chief Financial Officer (CFO), effective immediately, as well as Vasu Avadhanula as Chief Pro... Continue reading

Tags: Press Releases

ProFound AI Risk Outperforms Traditional, Widely-Accepted Breast Cancer Risk Models for Both Short-term and Long-term Risk Assessments

April 04, 2023
Category: Press Releases

ProFound AI Risk offered higher accuracy than Tyrer-Cuzick v8 for all women, regardless of menopausal status, breast density, and family history of breast cancer

 

NASHUA, N.H., April 4, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new clinical evidence published in the Journalof Clinical Oncology found ProFound AI® Risk for 2D Mammography is more accurate than Tyrer-Cuzick v8, a commonly used lifestyle risk model, for both short-term... Continue reading

Tags: Press Releases

iCAD Reports Financial Results for Fourth Quarter ended December 31, 2022 and Year End

March 28, 2023
Category: Press Releases

     Strategy focused on profitability by end of 2024, using current cash on hand

New leadership to host conference call and webcast today at 4:30 PM ET

 

NASHUA, N.H. – March 28, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported its financial and operating results for the twelve months ended December 31, 2022.

 

Highlig... Continue reading

Tags: Press Releases

© iCAD Inc.  All rights reserved.  iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.

Facebook icon Twitter icon LinkedIn icon